Sean Kim

Sean Kim is an accomplished professional in the field of Drug Metabolism and Pharmacokinetics (DMPK) with extensive experience spanning over two decades. Currently serving as Vice President of DMPK at Recludix Pharma since October 2024, Sean previously held leadership positions including Vice President of DMPK, M&S, and Clinical Pharmacology at IDRx and Vice President of Clinical Pharmacology, DMPK, and Toxicology at Valo. Before these roles, Sean excelled at Blueprint Medicines as Head of DMPK and Clinical Pharmacology and held senior positions at Novartis Institutes for BioMedical Research and Bristol-Myers Squibb. Early career experience includes significant roles at Wyeth Research and a foundation in drug safety and metabolism gained during a postdoctoral fellowship. Sean Kim earned a Ph.D. in Toxicology from Rutgers University, completed between 1993 and 1998.